Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $499.99 USD
Change Today -8.52 / -1.68%
Volume 806.8K
REGN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Munich
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - regeneron pharmaceuticals (REGN)

NameBoard RelationshipsTitleAge
Leonard S. Schleifer M.D., Ph.D.109 RelationshipsCo-Founder, Chief Executive Officer, President, Executive Director and Ex-Officio Member of Technology Committee62
Alfred G. Gilman M.D., Ph.D.11 RelationshipsCo-Founder, Independent Director, Chairman of Corporate Governance & Compliance Committee and Member of Technology Committee73
Robert E. Landry Jr.No RelationshipsChief Financial Officer and Senior Vice President of Finance51
George D. Yancopoulos M.D., Ph.D.24 RelationshipsChief Scientific Officer, Director, Member of Technology Committee and President of Regeneron Research Laboratories55
Joseph J. LaRosa 2 RelationshipsSenior Vice President, General Counsel and Secretary56

Board Members - regeneron pharmaceuticals (REGN)

NameBoard RelationshipsPrimary CompanyAge
Pindaros Roy Vagelos M.D.108 RelationshipsRegeneron Pharmaceuticals, Inc.85
Leonard S. Schleifer M.D., Ph.D.109 RelationshipsRegeneron Pharmaceuticals, Inc.62
Alfred G. Gilman M.D., Ph.D.11 RelationshipsRegeneron Pharmaceuticals, Inc.73
George D. Yancopoulos M.D., Ph.D.24 RelationshipsRegeneron Pharmaceuticals, Inc.55
George L. Sing 17 RelationshipsStemnion, Inc.66

Executive Committees* - regeneron pharmaceuticals (REGN)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeGeorge L. Sing 17 Relationships2 Executives
Compensation CommitteeMarc Tessier-Lavigne Ph.D. 76 Relationships4 Executives
Corporate Governance CommitteeAlfred G. Gilman M.D., Ph.D. 11 Relationships1 Executives
View REGN Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REGN:US $499.99 USD -8.52

REGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioMarin Pharmaceutical Inc $126.51 USD +0.06
Incyte Corp $115.88 USD -0.19
Kyowa Hakko Kirin Co Ltd ¥1,908 JPY -48.00
UCB SA €71.08 EUR -0.12
Vertex Pharmaceuticals Inc $126.99 USD +0.46
View Industry Companies
 

Industry Analysis

REGN

Industry Average

Valuation REGN Industry Range
Price/Earnings 100.0x
Price/Sales 15.4x
Price/Book 15.7x
Price/Cash Flow 116.1x
TEV/Sales 15.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REGENERON PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.